• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Triple-negative and basal-like breast cancer: implications for oncologists.三阴性和基底样乳腺癌：对肿瘤学家的启示
Curr Oncol. 2011 Aug;18(4):161-4. doi: 10.3747/co.v18i4.824.
2
Clinical significance of basal-like subtype in triple-negative breast cancer.三阴性乳腺癌中基底样亚型的临床意义
Breast Cancer. 2009;16(4):260-7. doi: 10.1007/s12282-009-0150-8. Epub 2009 Aug 22.
3
Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.鉴定猫三阴性基底样浸润性乳腺癌的免疫抑制亚型，即乳腺癌的自发模型。
Tumour Biol. 2020 Jan;42(1):1010428319901052. doi: 10.1177/1010428319901052.
4
Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.BRCA1基因的高甲基化：对散发性原发性三阴性乳腺癌预后生物标志物和治疗靶点的意义
Breast Cancer Res Treat. 2015 Apr;150(3):479-86. doi: 10.1007/s10549-015-3338-y. Epub 2015 Mar 18.
5
Triple-negative breast cancer: current state of the art.三阴性乳腺癌：当前的技术水平
Tumori. 2010 Nov-Dec;96(6):875-88.
6
Formin Proteins FHOD1 and INF2 in Triple-Negative Breast Cancer: Association With Basal Markers and Functional Activities.三阴性乳腺癌中的formin蛋白FHOD1和INF2：与基底标志物及功能活性的关联
Breast Cancer (Auckl). 2018 Aug 24;12:1178223418792247. doi: 10.1177/1178223418792247. eCollection 2018.
7
Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes.三阴性乳腺癌伴脑转移：基底样和非基底样生物学亚型的比较。
J Neurooncol. 2011 Dec;105(3):547-53. doi: 10.1007/s11060-011-0616-3. Epub 2011 Jun 9.
8
Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.基底细胞角蛋白和表皮生长因子受体的表达与三阴性乳腺癌女性的 BRCA1 突变状态无关。
Am J Surg Pathol. 2009 Jul;33(7):1093-7. doi: 10.1097/PAS.0b013e31819c1c93.
9
Management of primary and metastatic triple negative breast cancer: perceptions of oncologists from India.原发性和转移性三阴性乳腺癌的管理：印度肿瘤学家的看法
Indian J Cancer. 2011 Apr-Jun;48(2):158-64. doi: 10.4103/0019-509X.82874.
10
ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells.ΔNp63激活表皮生长因子受体（EGFR）信号通路，从而诱导三阴性基底样乳腺癌细胞的黏附丧失。
Breast Cancer Res Treat. 2017 Jun;163(3):475-484. doi: 10.1007/s10549-017-4216-6. Epub 2017 Mar 27.

引用本文的文献

1
Breastfeeding attributable fraction of triple negative breast cancer in the US.美国三阴性乳腺癌的母乳喂养归因分数
NPJ Breast Cancer. 2025 May 7;11(1):40. doi: 10.1038/s41523-025-00755-6.
2
Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies.乳腺癌干细胞与肿瘤异质性：特征与治疗策略
Cancers (Basel). 2024 Jul 7;16(13):2481. doi: 10.3390/cancers16132481.
3
Application of single-cell sequencing to the research of tumor microenvironment.单细胞测序在肿瘤微环境研究中的应用。
Front Immunol. 2023 Oct 27;14:1285540. doi: 10.3389/fimmu.2023.1285540. eCollection 2023.
4
Growth Inhibition, Caspase-Dependent Apoptosis, and S and G2/M Phase Arrest in Breast Cancer Cells Induced by Fluorine-Incorporated Gold I Compound, Ph3PAu[SC(OMe)=NC6H4F-3].含氟金（I）化合物Ph3PAu[SC(OMe)=NC6H4F-3]诱导乳腺癌细胞生长抑制、半胱天冬酶依赖性凋亡及S期和G2/M期阻滞
Int J Breast Cancer. 2022 Jul 21;2022:7168210. doi: 10.1155/2022/7168210. eCollection 2022.
5
The prognostic and predictive significance of cytokeratin 5/6 and epidermal growth factor receptor in metastatic triple-negative breast cancer treated with maintenance capecitabine.细胞角蛋白5/6和表皮生长因子受体在接受卡培他滨维持治疗的转移性三阴性乳腺癌中的预后及预测意义
Transl Cancer Res. 2021 Mar;10(3):1193-1203. doi: 10.21037/tcr-20-1760.
6
Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies.三阴性乳腺癌中的衰老诱导化疗耐药性及基于进化的治疗策略
Front Oncol. 2021 Jun 24;11:674354. doi: 10.3389/fonc.2021.674354. eCollection 2021.
7
Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks.单细胞RNA测序基于基因调控网络剖析三阴性乳腺癌的肿瘤内异质性。
Mol Ther Nucleic Acids. 2021 Jan 1;23:682-690. doi: 10.1016/j.omtn.2020.12.018. eCollection 2021 Mar 5.
8
Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype.妊娠期乳腺癌：显著倾向于三阴性表型
Front Oncol. 2020 Dec 23;10:580345. doi: 10.3389/fonc.2020.580345. eCollection 2020.
9
Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.在早期乳腺癌女性中，细胞角蛋白 5 和紧密连接蛋白 3 的表达与 BRCA1 和 BRCA2 种系突变的相关性。
BMC Cancer. 2019 Jul 15;19(1):695. doi: 10.1186/s12885-019-5908-6.
10
Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.乳腺癌组织中缺氧途径的激活与患者存活率与肿瘤抗坏血酸水平呈负相关。
BMC Cancer. 2019 Apr 3;19(1):307. doi: 10.1186/s12885-019-5503-x.

本文引用的文献

1
A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis.一项探索乳腺癌表型与预后之间调整后关联的单中心图表回顾研究。
Curr Oncol. 2011 Aug;18(4):191-6. doi: 10.3747/co.v18i4.815.
2
Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.乳腺癌中多个原癌基因酪氨酸激酶的激活是通过 PTPN12 磷酸酶的缺失实现的。
Cell. 2011 Mar 4;144(5):703-18. doi: 10.1016/j.cell.2011.02.003.
3
Uncovering a tumor suppressor for triple-negative breast cancers.揭示三阴性乳腺癌的肿瘤抑制因子。
Cell. 2011 Mar 4;144(5):638-40. doi: 10.1016/j.cell.2011.02.030.
4
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.内在型乳腺癌亚型、种族与卡罗来纳乳腺癌研究的长期生存。
Clin Cancer Res. 2010 Dec 15;16(24):6100-10. doi: 10.1158/1078-0432.CCR-10-1533.
5
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.伊沙匹隆联合卡培他滨治疗蒽环类和紫杉类药物治疗后体能状态降低的转移性乳腺癌患者：2 项 III 期研究中按体能状态汇总的疗效和安全性数据的分析。
Breast Cancer Res Treat. 2011 Feb;125(3):755-65. doi: 10.1007/s10549-010-1251-y. Epub 2010 Dec 3.
6
Triple-negative breast cancer.三阴性乳腺癌。
N Engl J Med. 2010 Nov 11;363(20):1938-48. doi: 10.1056/NEJMra1001389.
7
Synthetic lethal approaches to breast cancer therapy.合成致死方法治疗乳腺癌。
Nat Rev Clin Oncol. 2010 Dec;7(12):718-24. doi: 10.1038/nrclinonc.2010.172. Epub 2010 Oct 19.
8
Triple-negative breast cancer: disease entity or title of convenience?三阴性乳腺癌：疾病实体还是权宜之计？
Nat Rev Clin Oncol. 2010 Dec;7(12):683-92. doi: 10.1038/nrclinonc.2010.154. Epub 2010 Sep 28.
9
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.奥拉帕利治疗携带 BRCA1 或 BRCA2 突变的晚期乳腺癌患者的疗效：一项概念验证试验。
Lancet. 2010 Jul 24;376(9737):235-44. doi: 10.1016/S0140-6736(10)60892-6. Epub 2010 Jul 6.
10
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.新辅助顺铂在三阴性乳腺癌中的疗效。
J Clin Oncol. 2010 Mar 1;28(7):1145-53. doi: 10.1200/JCO.2009.22.4725. Epub 2010 Jan 25.

Triple-negative and basal-like breast cancer: implications for oncologists.

作者信息

Lachapelle J, Foulkes W D

机构信息

Department of Pathology, McGill University, Montreal, QC.

出版信息

Curr Oncol. 2011 Aug;18(4):161-4. doi: 10.3747/co.v18i4.824.

DOI:10.3747/co.v18i4.824
PMID:21874112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3149541/
Abstract
摘要